GO Plc

Prospectus • Dec 24, 2013

COMPANY ANNOUNCEMENT

The following is a Company announcement issued by GO p.l.c. ("the Company") pursuant to Malta Financial Services Authority Listing Rules.

Quote

The Company announces that Forthnet SA ('Forthnet') has earlier today issued an announcement, notifying its shareholders, that the Prospectus' Supplement for the share capital increase of the company with preemption rights in favour of existing shareholders will be available to investing public as of today. The company announcement issued by Forthnet is being reproduced below as part of this Company announcement.

24.12.2013

Forthnet S.A. Announcement

Forthnet S.A. (hereinafter the "Company" or "Forthnet") announces, according to the EU Regulation 809/2004 and the Law 3401/2005, as in force, that the Prospectus' Supplement for the share capital increase of the Company with pre-emption rights in favor of the existing shareholders and the trading of new shares in the Athens Stock Exchange resolved by the Extraordinary General Meeting of its Shareholders dated 23.08.2012, which was approved by the Capital Market Commission (hereinafter "CMC") on 23.12.2013, will be available to investing public as of 24.12.2013.

Specifically, the above Extraordinary General Meeting of Shareholders resolved, inter alia, the Company's share capital increase up to the amount of € 29.143.372,50 with the issue of up to 97.144.575 new common registered dematerialized shares with a nominal value of € 0,30 each (hereinafter the "New Shares"), payable in cash and with pre-emption rights in favor of the existing shareholders at a ratio of 15 new shares for 2 existing shares. The authorized by the Extraordinary General Meeting of Shareholders of 23.08.2012 Board of Directors at its meeting on 21.08.2013 determined the issue price of the New Shares at € 0,30 (hereinafter the "Issue Price") for each New Share, which, according to the Extraordinary General Meeting of Shareholders of 23.08.2012 may be higher than the market price of the existing shares at the ex-rights date. The Company's Board of Directors of 23/11/2013, as authorized by the Extraordinary General Meeting of Shareholders of 23.08.2012, resolved that the beneficiaries of pre-emption rights, after having fully exercised their pre-emption rights, will be entitled to an oversubscription right, as referred in detail in the approved by the CMC on 29.11.2013 Prospectus. In total up to 97.144.575 new common registered shares will be issued with a nominal value of € 0,30 at the Issue Price of € 0,30 for each new share, while it is expected that the raised funds will amount up to €29.143.372,50.

The shares to be issued as a result of the share capital increase payable in cash shall be admitted for trading to the Athens Stock Exchange, following relevant application, in the "Under Surveillance" section. For the admission for trading of the new shares a prior approval by the A.S.E. is required.

The above mentioned Prospectus' Supplement involves, according to article 16 of the Law 3401/ 2005, new information in comparison to the information already included in the Prospectus that may have an influence on the assessment of the new common registered shares of the Company and has arisen or has been noted following approval of the Prospectus by the Board of Directors of the CMC (29.11.2013).

According to para. 3 of article 16 of the Law 3401/2005, investors that have already subscribed for the purchase of securities to be issued following the resolution of the 23.08.2012 Extraordinary General Meeting of Shareholders before publication of the Prospectus' Supplement, have the right to withdraw within two (2) business days from the publication of the Supplement at the latest.

DATE	ACTION
23.12.2013	Prospectus' Supplement approval by the Board of Directors of the CMC
24.12.2013	Publication of the Prospectus' Supplement (publication in the websites of the Company, A.S.E and C.M.C.)
24.12.2013	Publication of the announcement for the Prospectus' Supplement distribution in the websites of the Company and A.S.E.
27.12.2013	Publication of the announcement for the Prospectus' Supplement distribution in Press
27.12.2013	End of trading of pre-emption rights
27.12.2013	Commencement of withdrawal rights period
30.12.2013	Termination of withdrawal rights period
03.01.2014	End of exercise of the pre-emption and oversubscription rights
09.01.2014	Publication in the ASE Daily Bulletin as well as in the websites of ASE and the Company of the Announcement for the rate of subscription of the SCI as a result of the exercise of pre-emption rights and allocation of any unsubscribed shares
14.01.2014	Approval by A.S.E. for the admission for trading of the new shares*
14.01.2014	Announcement in the Daily Bulletin and the website of ATHEX regarding the date of commencement of trading of the new shares
16.01.2014	Beginning of trading of the new shares

The updated planned timetable for the share capital increase (hereinafter the "SCI") is as follows:

* Subject to convocation of the Board of Directors/ Operations' Committee of A.S.E. on the above date.

It is noted that the above timetable depends on several unforeseeable factors and may be subject to changes. For the share capital increase procedure and its implementation timetable there will be the necessary announcements for the information of the investing public according to the law.

The Prospectus' Supplement relating to the SCI, as approved by the Board of Directors of the Capital Market Commission on 23.12.2013, will be available in electronic format at the Company's website («http://www.forthnet.gr»), ASE website

(«http://www.ase.gr/content/gr/Companies/ListedCo/Prospectus/»), as well as CMC website («http://www.hcmc.gr»), according to article 14 para. 2 of L. 3401/2005, as in force. Also, the Prospectus' Supplement, will be available in printed form, free of charge upon request, at the Company's offices, at Kantza, Pallini of Attica, extension of Manis str., P.C. 153 51.

For more information, shareholders may contact Mr. George Dermitzakis at the Company's IR Department (tel. 211-9552865 and 211-9552869) during business days and hours.

Unquote

Dr. Francis Galea Salomone LL.D. Company Secretary

24 December 2013